Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
This review identifies possible pharmacological targets for inflammatory bowel disease (IBD) within the IL-23/IL-17 axis. Specifically, there are several targets within the IL-23/IL-17 pathways for potential pharmacological intervention with antibodies or small molecule inhibitors. These targets inc...
Saved in:
Main Author: | Leo R. Fitzpatrick (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overexpression and Selectively Regulatory Roles of IL-23/IL-17 Axis in the Lesions of Oral Lichen Planus
by: Rui Lu, et al.
Published: (2014) -
IL-33/IL-31 Axis: A Potential Inflammatory Pathway
by: Eleonora Di Salvo, et al.
Published: (2018) -
Targeted Delivery of the HLA-B∗27-Binding Peptide into the Endoplasmic Reticulum Suppresses the IL-23/IL-17 Axis of Immune Cells in Spondylarthritis
by: Hui-Chun Yu, et al.
Published: (2017) -
Hmgb1-IL-23-IL-17-IL-6-Stat3 Axis Promotes Tumor Growth in Murine Models of Melanoma
by: Qiu Tang, et al.
Published: (2013) -
IL-23/IL-17 axis levels in gingival crevicular fluid of subjects with periodontal disease: a systematic review
by: Mario Alberto Alarcón-Sánchez, et al.
Published: (2024)